Key result
Mouse gene profiling identifies DPPI and TIMP-3 as key drivers of early lung fibrosis inflammation.
The study identifies DPPI and tissue inhibitor of matrix metalloproteinase-3 as key genes in the early inflammatory response to bleomycin, though DPPI deletion alone does not prevent fibrosis in sensitive mice.
Answers are grounded in this paper and cite their sources.
Should not change clinical practice in pulmonary fibrosis; leaves open validation of DPPI and TIMP-3 as therapeutic targets in humans.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Pottier et al. (2007) studied Bleomycin-induced lung fibrosis. Bleomycin instillation vs. BALB/c mice (resistant strain) was evaluated on Gene expression profiles and lung fibrosis development. Expression of 25 genes differed between sensitive and resistant mice, identifying DPPI and tissue inhibitor of matrix metalloproteinase-3 as key factors in early inflammatory events of lung fibrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: